The estimated Net Worth of Charles Elliott Sigal is at least $78.3 Mille dollars as of 1 March 2023. Charles Sigal owns over 2,500 units of Vir Biotechnology Inc stock worth over $78,300 and over the last 9 years Charles sold VIR stock worth over $0.
Charles has made over 5 trades of the Vir Biotechnology Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Charles bought 2,500 units of VIR stock worth $56,825 on 1 March 2023.
The largest trade Charles's ever made was buying 45,000 units of Vir Biotechnology Inc stock on 16 May 2016 worth over $68,850. On average, Charles trades about 2,258 units every 80 days since 2016. As of 1 March 2023 Charles still owns at least 10,000 units of Vir Biotechnology Inc stock.
You can see the complete history of Charles Sigal stock trades at the bottom of the page.
Charles's mailing address filed with the SEC is C/O VIR BIOTECHNOLOGY, INC., 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158.
Over the last 5 years, insiders at Vir Biotechnology Inc have traded over $197,171,926 worth of Vir Biotechnology Inc stock and bought 6,960,011 units worth $139,246,875 . The most active insiders traders include Norbert W Bischofberger, Endurance (Cayman) Ltd Sb I... e Kristina Burow. On average, Vir Biotechnology Inc executives and independent directors trade stock every 7 days with the average trade being worth of $478,115. The most recent stock trade was executed by Janet Napolitano on 9 September 2024, trading 12,190 units of VIR stock currently worth $95,082.
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Vir Biotechnology Inc executives and other stock owners filed with the SEC include: